Jordan Graff, MD
Retina Specialist · Phoenix, AZNPI 1952487829
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Genentech USA, Inc. at 52.5% of the total. 2025 is the largest year on record at $147,380, 4.2 times the $35,473 reported in 2019. Among retina specialist clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 418 payments — averaging $1155.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$254K
- F. Hoffmann-la Roche AG$64K
- Genentech, Inc.$59K
- Roche Products Limited$40K
- Ocular Therapeutix, Inc.$14K
- AbbVie$13K
- plus $39K from 20 others
Across 394 payments — averaging $10,164 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$3.7M
- Kyowa Kirin, Inc.$185K
- Roche TCRC, Inc.$62K
- F. Hoffmann-la Roche AG$35K
- Regeneron$16K
- Astellas Pharma Global Development$8K
- plus $6K from 1 others
What the payments were for
- Consulting fees$240,39350%
- Speaking & faculty fees$160,29933%
- Travel & lodging$65,75214%
- Food & beverage$15,8353%
- Education$5740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 217 | $253,733 |
| F. Hoffmann-la Roche AG | 24 | $64,132 |
| Genentech, Inc. | 22 | $59,126 |
| Roche Products Limited | 7 | $40,189 |
| Ocular Therapeutix, Inc. | 8 | $14,295 |
| AbbVie(2 entities) | 12 | $12,592 |
| Regeneron Healthcare Solutions, Inc. | 33 | $10,852 |
| Apellis Pharmaceuticals, Inc. | 16 | $7,503 |
| Hoffmann-la Roche Limited | 2 | $7,265 |
| Alimera Sciences, Inc. | 15 | $6,243 |
| Harrow Eye, LLC | 2 | $3,500 |
| Kyowa Kirin, Inc. | 9 | $1,581 |
| Novartis | 15 | $706 |
| Regeneron | 4 | $256 |
| Astellas Pharma US Inc | 9 | $226 |
| Biogen | 5 | $180 |
| Bausch & Lomb Americas Inc. | 6 | $121 |
| Sight Sciences, Inc. | 1 | $116 |
| Eyepoint US, Inc. | 1 | $49 |
| Rayner Intraocular Lenses Limited | 2 | $47 |
| Aerie Pharmaceuticals, Inc. | 2 | $37 |
| Alcon | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $18 |
| Kala Pharmaceuticals, Inc. | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$482,854 in reported general payments places this provider in the 95th percentile of 30 retina specialist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 436 | $12,436 |
| Ofloxacin | 383 | $4,051 |
| Dorzolamide Hcl | 21 | $608 |
| Latanoprost | 32 | $235 |
| Brimonidine Tartrate | 16 | $112 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Phoenix
- Rahul ReddyPhoenix$333K
- Henry KwongPhoenix$147K
- Benjamin BakallPhoenix$137K
- Jaime GaitanPhoenix$114K
- Stephen de SouzaPhoenix$95K
- Joseph BryanPhoenix$88K
- Alan GordonPhoenix$86K
- Suhail AlamPhoenix$24K
- Rima PatelPhoenix$19K
- Matthew WelchPhoenix$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.